Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression

International Journal of Neuropsychopharmacology

Volumn 17, Issue 11, 2014, Pages 1805-1813

  Shiroma, Paulo R ^a,b   Albott, C Sophia ^a,b   Johns, Brian ^b,c   Thuras, Paul ^a,b   Wels, Joseph ^a   Lim, Kelvin O ^a,b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NORTH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

glutamate; ketamine; treatment resistant depression; veterans

Indexed keywords

KETAMINE; ANESTHETIC AGENT;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; DISEASE SEVERITY; FOLLOW UP; HUMAN; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RELAPSE; TREATMENT RESISTANT DEPRESSION; VELOCITY; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY; ADOLESCENT; AGED; DEPRESSION; DRUG EFFECTS; FEMALE; LEARNING; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANESTHETICS, DISSOCIATIVE; ATTENTION; COGNITION; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KETAMINE; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; VERBAL LEARNING; YOUNG ADULT;

EID: 84925650392     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145714001011     Document Type: Article

References (49)

1. Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A (1998) Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43:811-816.
2. Aldrete JA (1995) The post-anesthesia recovery score revisited. J Clin Anesth 7:89-91.
3. Alexopoulos GS, Kiosses DN, Heo M, Murphy CF, Shanmugham B, Gunning-Dixon F (2005) Executive dysfunction and the course of geriatric depression. Biol Psychiatry 58:204-210.
4. Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
5. Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS, Mazure CM (1998) Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS). J Trauma Stress 11:125-136.
6. Collie A, Maruff P, Darby DG, McStephen M (2003a) The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc 9:419-428.
7. Collie A, Maruff P, Darby DG, McStephen M (2003b) The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc 9:419-428.
8. Corssen G, Oget S, Reed PC (1971) Computerized evaluation of psychic effects of ketamine. Anesth Analg 50:397-401.
9. Diamond PR, Farmery AD, Atkinson S, Haldar J, Williams N, Cowen PJ, Geddes JR, McShane R (2014) Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic. J Psychopharmacol 6:536-544.
10. Falleti MG, Maruff P, Collie A, Darby DG (2006) Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol 28:1095-1112.
11. First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID - CV). Washington, DC: American Psychiatric Press.
12. Fletcher PC, Honey GD (2006) Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits. Trends Cogn Sci 10:167-174.
13. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
14. Fredrickson J, Maruff P, Woodward M, Moore L, Fredrickson A, Sach J, Darby D (2010) Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies. Neuroepidemiology 34:65-75.
15. Green SM, Li J (2000) Ketamine in adults: what emergency physicians need to know about patient selection and emergence reactions. Acad Emerg Med 7:278-281.
16. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
17. Hartvig P, Valtysson J, Lindner KJ, Kristensen J, Karlsten R, Gustafsson LL, Persson J, Svensson JO, Oye I, Antoni G (1995) Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers. Clin Pharmacol Ther 58:165-173.
18. Jansen KL (1990) Ketamine-can chronic use impair memory? Int J Addict 25:133-139.
19. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr., Charney DS (1994a) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
20. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr., Charney DS (1994b) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
21. Krystal JH, Perry EB Jr., Gueorguieva R, Belger A, Madonick SH, Abi-Dargham A, Cooper TB, Macdougall L, Abi-Saab W, D'Souza DC (2005) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62:985-994.
22. LaPorte DJ, Blaxton TA, Michaelidis T, Robertson DU, Weiler MA, Tamminga CA, Lahti AC (2005) Subtle effects of ketamine on memory when administered following stimulus presentation. Psychopharmacology (Berl) 180:385-390.
23. Luckenbaugh DA, Ibrahim L, Brutsche N, Franco-Chaves J, Mathews D, Marquardt CA, Cassarly C, Zarate CA Jr. (2012) Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression. Bipolar Disord 14:880-887.
24. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14:301-307.
25. Maruff P, Thomas E, Cysique L, Brew B, Collie A, Snyder P, Pietrzak RH (2009) Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol 24:165-178.
26. McLennan SN, Mathias JL (2010) The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review. Int J Geriatr Psychiatry 25:933-944.
27. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927.
28. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
29. Moretti RJ, Hassan SZ, Goodman LI, Meltzer HY (1984) Comparison of ketamine and thiopental in healthy volunteers: effects on mental status, mood, and personality. Anesth Analg 63:1087-1096.
30. Morgan CJ, Curran HV (2006) Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology (Berl) 188:408-424.
31. Morgan CJ, Mofeez A, Brandner B, Bromley L, Curran HV (2004) Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29:208-218.
32. Morgan CJ, Muetzelfeldt L, Curran HV (2009) Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Addiction 104:77-87.
33. Morgan CJ, Curran HV, Independent Scientific Committee on Drugs (2012) Ketamine use: a review. Addiction 107:27-38.
34. Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV (2013a) Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 74:250-256.
35. Murrough JW, Wan LB, Iacoviello B, Collins KA, Solon C, Glicksberg B, Perez AM, Mathew SJ, Charney DS, Iosifescu DV, Burdick KE (2013b) Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology (Berl) 11 Sept. 2013 (Epub ahead of print).
36. Narendran R, Frankle WG, Keefe R, Gil R, Martinez D, Slifstein M, Kegeles LS, Talbot PS, Huang Y, Hwang DR, Khenissi L, Cooper TB, Laruelle M, Abi-Dargham A (2005) Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry 162:2352-2359.
37. Overall JGDR., (1962) The brief psychiatric rating scale. Psychol Rep 10:799-812.
38. Parwani A, Weiler MA, Blaxton TA, Warfel D, Hardin M, Frey K, Lahti AC (2005) The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology (Berl) 183:265-274.
39. Perry EB Jr., Cramer JA, Cho HS, Petrakis IL, Karper LP, Genovese A, O'Donnell E, Krystal JH, D'Souza DC, Yale Ketamine Study Group (2007) Psychiatric safety of ketamine in psychopharmacology research. Psychopharmacology (Berl) 192:253-260.
40. Phelps LE, Brutsche N, Moral JR, Luckenbaugh DA, Manji HK, Zarate CA Jr. (2009) Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry 65:181-184.
41. Popke EJ, Allen RR, Pearson EC, Hammond TG, Paule MG (2001) Differential effects of two NMDA receptor antagonists on cognitive-behavioral performance in young nonhuman primates II. Neurotoxicol Teratol 23:333-347.
42. Rami-Gonzalez L, Bernardo M, Boget T, Salamero M, Gil-Verona JA, Junque C (2001) Subtypes of memory dysfunction associated with ECT: characteristics and neurobiological bases. J Ect 17:129-135.
43. Rasmussen KG, Lineberry TW, Galardy CW, Kung S, Lapid MI, Palmer BA, Ritter MJ, Schak KM, Sola CL, Hanson AJ, Frye MA (2013) Serial infusions of low-dose ketamine for major depression. J Psychopharmacol 27:444-450.
44. Reisner AD (2003) The electroconvulsive therapy controversy: evidence and ethics. Neuropsychol Rev 13:199-219.
45. Sackeim HA (2001) The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62(Suppl. 16):10-17.
46. Shiroma PR, Johns B, Kuskowski M, Wels J, Thuras P, Albott CS, Lim KO (2014) Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression. J Affect Disord 155:123-129.
47. Snyder PJ, Werth J, Giordani B, Caveney AF, Feltner D, Maruff P (2005) A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam. Hum Psychopharmacol 20:263-273.
48. UK ECT Review Group (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361:799-808.
49. Verwijk E, Comijs HC, Kok RM, Spaans HP, Stek ML, Scherder EJ (2012) Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review. J Affect Disord 140:233-243.